Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
14Dec2025
  • Home
  • About
  • News
  • Subscribe
14Dec2025
Cost Curve NewsCost Curve News
Cost Curve News

The IRA Is Disincentivizing the Development of Higher-Value Medicines, Health Affairs Study Says

Full disclosure: I’m not sure about the publication schedule for the rest of the week. It’s election day here in the United States. I haven’t written much about the election
1 year ago
Keep Reading
Cost Curve News

Lilly Joins Sanofi’s Legal Fight to Get HRSA to Open Up About How 340B Really Works

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
1 year ago
Keep Reading
Cost Curve News

What’s Scarier: Halloween or Open Enrollment?

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
1 year ago
Keep Reading
Cost Curve News

It’s Probably a Good Day to Rake Leaves

I’m taking a breather of sorts today. There’s plenty of news and commentary out there, but most of it is fairly marginal. So it’s a light read.  *** If you
1 year ago
Keep Reading
Cost Curve News

Survey Data Shows Employers Want to Drive the PBM Conversation Toward Value and Transparency

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
1 year ago
Keep Reading
Cost Curve News

New Data Underscores that Access Barriers for Patients Are High … and Getting Higher

It’s not often that I get excited about more email, but lawyer Bill Sarraille has a new newsletter that is worth the click. I link to Bill’s work on LinkedIn
1 year ago
Keep Reading
Cost Curve News

Beware PBMs Bearing Obesity-Drug Data

Programming Note: Cost Curve is off tomorrow. Back Monday. Of course, that’s what I said last week, too, and look where that got me. There is a new analysis from
1 year ago
Keep Reading
Cost Curve News

The 340B Content Keeps Coming: Covered Entities Respond to the HRSA Numbers, a Worthwhile Poll, and More

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
1 year ago
Keep Reading
Cost Curve News

More Thinking Around the Two Big Stories of the Moment: 340B Numbers and PBMs Killing Pharmacy

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
1 year ago
Keep Reading
Cost Curve News

More 340B Math Showing that the Drug Discount Program Is Getting Unimaginingly Large

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
1 year ago
Keep Reading
262728

Latest Posts

A New Tracker for Watching Meds That Might See Prices Slashed

December 10, 2025

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

December 9, 2025

Reimbursement for Hep B Shots Should Remain Stable Even as CDC Panel Undermines the Vaccine

December 8, 2025

A New Health Affairs Forefront Piece Seeks to Reset the ‘Pharm-to-Table’ Conversation

December 5, 2025

Companies and Nations Respond to the U.S.-U.K. Agreement to Eliminate Tariffs, Boost Drug Prices

December 4, 2025

Popular

A New Tracker for Watching Meds That Might See Prices Slashed

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

Reimbursement for Hep B Shots Should Remain Stable Even as CDC Panel Undermines the Vaccine

A New Health Affairs Forefront Piece Seeks to Reset the ‘Pharm-to-Table’ Conversation

Companies and Nations Respond to the U.S.-U.K. Agreement to Eliminate Tariffs, Boost Drug Prices

The Need-to-Know on a Slow News Day: More MFN Deals Are Coming, and Why Pharma Thinks the U.S./U.K. Trade Agreement Should Be a Model

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,939)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (2,030)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,921)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,719)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,712)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

A New Tracker for Watching Meds That Might See Prices Slashed

December 10, 2025

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

December 9, 2025

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2025 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe